Sign in
ITRM Stock Price, Chart, Stats & News
Iterum Therapeutics plc
Save
Iterum Therapeutics plc (ITRM) does not currently pay a dividend.
1.60M
Market cap
–
Current P/E
–
Forward P/E
ITRM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -171.28% |
Operating margin | -5202.82% |
Pretax margin | -6842.31% |
Net margin | -6913.08% |
Effective tax rate | -1.03% |
ROA | -82.95% |
ROE | 602.38% |
D/E | -4.57x |
Interest coverage ratio | -8.83x |
ITRM valuation
P/E | – |
P/S | 4.86x |
P/B | -0.22x |
P/CF | -0.08x |
P/FCF | -0.10x |
P/OCF | -0.08x |
PEG | -0.01x |
EV multiple | 0.90x |
About
Iterum Therapeutics plc is a clinical-stage biopharmaceutical firm dedicated to the development and commercialization of anti-infective treatments. The company operates across Ireland, Bermuda, and the United States. Its primary therapeutic candidate is sulopenem, an innovative antimicrobial compound available in both oral and intravenous formulations.
Similar securities
Based on sector and market capitalization
Report issue